Drugs / Laninamivir
last change Feb 2023 re-read 2 minutes ago

Laninamivir

also known as INAVIR · R-125489

Small molecule

Developed for
influenza
Investigated by
University of Oxford

Trials 1 · a red edge is where a trial was stopped

2024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05648448 Feb 2023 → Jan 2027 expected influenza University of Oxford Recruiting No outcome recorded

Press releases naming this drug 8 releases

DateIssuerRelease
2018-03-26 Daiichi Sankyo Japanese Government to Stockpile Inavir® Anti-influenza Drug for Combatting Pandemic Influenza Threats in Japan daiichisankyo.com
2016-08-26 Daiichi Sankyo Daiichi Sankyo Receives Additional Dosage Regimen Approval in Japan for Long-acting Neuraminidase Inhibitor Inavir® Dry Powder Inhaler 20mg daiichisankyo.com
2013-12-20 Daiichi Sankyo Daiichi Sankyo Receives Approval for the Use of Inavir® to Prevent Influenza daiichisankyo.com
2012-11-15 Daiichi Sankyo Daiichi Sankyo Submits Application for Approval to Manufacture and Market Inavir(R) Dry Powder Inhaler, an Influenza Antiviral for the Prevention of Influenza in Japan daiichisankyo.com
2012-08-22 Daiichi Sankyo Positive Phase 3 Clinical Study Results for Inavir(R) Dry Powder Inhaler, an Influenza Antiviral, for the Prevention of Influenza daiichisankyo.com
2010-10-19 Daiichi Sankyo Daiichi Sankyo Launches Anti-Influenza Inavir(R) Inhaler daiichisankyo.com
2010-09-29 Daiichi Sankyo Announcement of Launch Date in Japan for Inavir(R) Influenza Antiviral Inhalant daiichisankyo.com
2010-09-10 Daiichi Sankyo Daiichi Sankyo Receives Approval to Manufacture and Market Inavir(R) Influenza Antiviral Inhalant for Treatment in Japan daiichisankyo.com

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Laninamivir ClinicalTrials.gov intervention name — accepted as the source's own label NCT05648448
Known as INAVIR “Laninamivir (INAVIR®)” NCT05648448
Known as R-125489 ChEMBL registry synonym — accepted as the source's own label CHEMBL466246
Modality Small molecule CHEMBL466246
Route Inhaled Inhaled laninamivir” NCT05648448